Menopause Care Prompts

I'm a primary care provider looking to improve my approach to menopause care. Based on current evidence: 1. Could you provide a detailed algorithm for evaluating and managing patients with vasomotor symptoms, including when to use hormone therapy versus non-hormonal options? 2. I'd like more information about the practical differences between synthetic versus bioidentical hormone options, including specific brand names and dosing strategies for both. 3. Can you explain the cardiovascular timing hypothesis in hormone therapy in more detail and how it should influence my prescribing practices? 4. What are the latest updates on neurokinin receptor antagonists like fezolinetant, including real-world effectiveness, insurance coverage issues, and monitoring protocols? 5. How can I better guide patients through a shared decision-making process about hormone therapy, including specific questions or visual aids that help explain the risk-benefit profile? Please include practical clinical pearls and any new evidence that might have emerged since early 2025.